Beryl Drugs Ltd.

BERLDRG

₹21.0

-0.99% (-0.21)

Market Cap

₹11 Cr.

P/E

18.39

Key Ratios

Edit Ratio's

Market cap

11.00 Cr

18.39

Prom Holding

26.38 %

ROE (%)

8.61

ROCE (%)

12.76

Div Yield (%)

Sales

22.55 Cr

OPM (%)

11.71 %

Debt to Equity

0.57

Edit Ratio's

About

Beryl Drugs Limited is incorporated on August 24, 1993 under the provisions of The Companies A… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Share price

Share price has decreased over last 10 years more due to derating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Beryl Drugs Ltd. Business

What does Beryl Drugs do?

Beryl Drugs Limited, established in 1993, specializes in pharmaceutical manufacturing with a global presence offering research, development, contract manufacturing, and veterinary products.

Who are the competitors of Beryl Drugs?

Beryl Drugs major competitors are Decipher Labs, Colinz Laboratories, Unjha Formulations, Hind Bio Science, Ortin Global, Venmax Drugs&Pharma, Ganga Pharma..
Market Cap of Beryl Drugs is ₹11 Crs.
While the median market cap of its peers are ₹11 Crs.

Is Beryl Drugs financially stable compared to its competitors?

Beryl Drugs seems to be less financially stable compared to its competitors.
Altman Z score of Beryl Drugs is 2.94 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Beryl Drugs Ltd.

Beryl Drugs Ltd.

Key Ratios

About

Timeline

Company Timeline

8 Yes

2 Neutral

7 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Price & Performance

Capex vs ROCE

ROE

Working Capital

Balance Sheet Strength

Current vs Historic Valuation

Debt

Share price

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

What does Beryl Drugs do?

Who are the competitors of Beryl Drugs?

Is Beryl Drugs financially stable compared to its competitors?

SIGN UP FOR FREE